Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

Niagen Bioscience CEO Robert Fried discusses the science of NAD, the problems with the supplement industry, and how his company is leading the way in anti-aging research.

Ben Lamm, CEO of Colossal Biosciences, wanted to ensure his brand was approachable to all, fun, educational and full of ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

On the last 16 sessions grey market activities, the lowest GMP is Rs 0, while the highest GMP is Rs 157. So, if we go by the ...

Harvard Bioscience has yet another leadership shakeup as the Holliston-based biotech firm’s CEO is set to retire and two new ...

We recently published 10 Stocks Exploded Over 100%; One Shockingly Soared 11,000%. Regencell Bioscience Holdings Limited ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human ...

Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board membersQ2 '25 revenue anticipated to be $20.4 million and Company reiterates pr ...